Zenicor Medical Systems operates in the medical technology sector. The company focuses on diagnostics in cardiac healthcare. The technology is based on the company's platform, which is used to identify and diagnose potential atrial fibrillation and cardiac fibrillation disorders. The largest operations are found around the European market. The company was established in 2003 and is headquartered in Stockholm.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Ragnar Winell | 16,85 | 16,85 | 2025-06-26 |
| Sonny Norström | 9,96 | 9,96 | 2025-06-26 |
| Mats Palerius | 8,41 | 8,41 | 2025-06-26 |
| Gundars Rasmanis | 6,56 | 6,56 | 2025-06-26 |
| Avanza Pension | 5,44 | 5,44 | 2025-06-26 |
| Sören Mellstig | 5,08 | 5,08 | 2025-06-26 |
| Nordnet Pensionsförsäkring | 4,71 | 4,71 | 2025-06-26 |
| Försäkringsaktiebolaget Skandia | 3,21 | 3,21 | 2025-06-26 |
| Pei-Quan Ye | 2,74 | 2,74 | 2025-06-26 |
| Staffan Eriksson | 2,04 | 2,04 | 2025-06-26 |
2025-10-30 Delårsrapport 2025-Q3
2026-02-13 Bokslutskommuniké 2025
